Phase 2 study of pembrolizumab alone or combined with acalabrutinib in platinum-refractory metastatic urothelial carcinoma (mUC)
Conference Paper
Full Text
Duke Authors
Cited Authors
- Zhang, T; Harrison, M; O'Donnell, P; Alva, A; Hahn, N; Appleman, LJ; Cetnar, J; Burke, J; Fleming, M; Milowsky, M; Mortazavi, A; Shore, N; Schmidt, EV; Kresja, C; Chen, T; Bitman, B; Izumi, R; Hamdy, A; George, DJ
Published Date
- September 1, 2017
Published In
Volume / Issue
- 28 /
Published By
Pages
- 2
Electronic International Standard Serial Number (EISSN)
- 1569-8041
International Standard Serial Number (ISSN)
- 0923-7534
Conference Name
- 42nd European-Society-for-Medical-Oncology Congress (ESMO)
Conference Location
- Madrid, SPAIN
Conference Start Date
- September 8, 2017
Conference End Date
- September 12, 2017